MiMedx Execs To Pay SEC Nearly $2M To End Fraud Claims
By Emilie Ruscoe ( June 8, 2023, 5:38 PM EDT) -- Two convicted former executives of skin graft biotechnology company MiMedx have agreed to pay nearly $2 million to the U.S. Securities and Exchange Commission to resolve claims they played a role in orchestrating a "pervasive, long-running fraud" that saw the company strike backroom deals with distributors to misstate millions of dollars of revenue in its public filings....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.